Abbott Laboratories buy Daiwa Capital Markets
Start price
21.10.25
/
50%
€110.72
Target price
21.10.26
€116.80
Performance (%)
-13.71%
Price
10:53
€95.54
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.71%. This prediction currently runs until 21.10.26. The prediction end date can be changed by Daiwa_Capital_Market at any time. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 4.375% | 4.375% |
| iShares Core DAX® | 1.301% | -1.386% |
| iShares Nasdaq 100 | 0.612% | -4.172% |
| iShares Nikkei 225® | 8.772% | 9.777% |
| iShares S&P 500 | 0.254% | -2.301% |
Comments by Daiwa_Capital_Market for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at Daiwa Capital Markets from $134.00 to $136.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat